HHS Secretary RFK Jr. just dropped major news: the FDA is removing 12 peptides from its restrictive Category 2 list reversing the 2023 crackdown that shut down compounding pharmacies and fueled BPC 157 Peptide Research, Benefits & US Sourcing Peptide Intel RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Check out FDAs new roster of bulk drug substances being pulled from use in compounding. Youll see BPC 157 and TB 500 among the various peptides added to the list of category 2 substances The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting